https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Surgical Plating vs Closed Reduction for Fractures in the Distal Radius in Older Patients: A Randomized Clinical Trial https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49854 Tue 06 Jun 2023 14:56:50 AEST ]]> Undiagnosed pancreatic exocrine insufficiency and chronic pancreatitis in functional GI disorder patients with diarrhea or abdominal pain https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:31027 Sat 24 Mar 2018 07:34:52 AEDT ]]> Plating vs Closed Reduction for Fractures in the Distal Radius in Older Patients: A Secondary Analysis of a Randomized Clinical Trial https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48081 Fri 24 Feb 2023 14:27:56 AEDT ]]> Long-term omega-3 polyunsaturated fatty acid supplementation reduces the recurrence of persistent atrial fibrillation after electrical cardioversion https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:23784 1 month prior to electrical cardioversion and continued thereafter reduces recurrence of persistent AF. Methods: This was an open-label, randomized study of 178 patients with persistent AF >1-month duration. Participants were assigned to control group (n = 87) or omega-3 group (6 g/d fish oil; n = 91) and underwent cardioversion 1 month later. Concurrent antiarrhythmic use of sotalol or amiodarone was permitted. Fish oil was continued till return of persistent AF or a maximum of 1 year. Intention-to-treat analysis was performed for the primary end point defined as the recurrence of persistent AF. Results: Mean duration of fish oil intake was 56 days precardioversion and a total of 242 days in follow-up. Eicosapentaenoic acid and docosahexaenoic acid, the active components of fish oils, were 1.8-fold and 2.1-fold higher, respectively, in the omega-3 group compared with controls at the time of cardioversion (P <.001). At 90 days, 38.5% of the patients receiving omega-3 fatty acid supplement had AF recurrence compared with 77.5% of the controls (hazard ratio [omega-3 vs control] 0.38; 95% confidence interval 0.27−0.56; P <.001). Omega-3 intake was associated with a significant reduction in AF recurrence with or without concurrent antiarrhythmic drugs. Conclusions: Omega-3 polyunsaturated fatty acid supplementation commenced >1 month prior to electrical cardioversion and continued thereafter reduces the recurrence of persistent AF. Randomized controlled trials on long-term fish oil supplementation are needed to confirm these findings.]]> Fri 21 Oct 2016 15:57:37 AEDT ]]>